Neshat et al. synthesized and evaluated a series of indole-based heterocyclic conjugates as cholinesterase inhibitors for potential Alzheimer’s disease treatment [178]. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.